Bacteriophage treatment decontaminates infant formula
6 November 2015 • Author(s): Victoria White
A bacteriophage treatment has shown strong anti-microbial activity against a type of foodborne bacterium that often kills infants after infecting them via infant formula.
Phages are viruses that infect only bacteria.
In the study, the phage, called “CR5,” showed high antimicrobial activity against the bacterium, Cronobacter sakazakii, as well as against several other species of Cronobacter, which can also cause dangerous illness, said Sangryeol Ryu, professor in the Department of Agricultural Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Korea.
The research was conducted using infant formula that had been contaminated with C. sakazakii. “Interestingly, CR5 killed C. sakazakii quickly, and no C. sakazakii was detected in the infant formula after 10 hours had passed,” said Ryu.
Ryu said that the phage is safe for humans, noting that his analysis of its genome revealed neither toxin gene nor virulence factor. In 2006, the US Food and Drug Administration approved the use of bacteriophages as biocontrol agents in foods. But the agency does not allow the use of antibiotics in infant formula.
Other foodborne pathogens could be controlled by phages
Bacteriophages are abundant in the environment, which means they are ecologically friendly, said Ryu. “They infect and kill only bacteria, which means they could be used as novel biocontrol agents and even as natural food preservatives,” he added, noting that other foodborne pathogens could also be controlled, by other types of phages.
Cronobacter, the target bacterial genus of the phage, CR5, is a family of closely related species that cause illness in people of all ages. These bacteria kill up to 40% of infected infants. Additionally, those that survive can face long-term neurological problems.
“C. sakazakii-contaminated infant formula has been considered an unsolved problem because antibiotics cannot be used,” said Ryu, adding that C. sakazakii has been known to have multiple antibiotic resistance genes. “In this study, we proved that C. sakazakii-phage CR5 is an efficient biocontrol agent in infant formula. Therefore, this bacteriophage treatment is a promising approach to solve this problem.”
ABF Ingredients ANDEROL EUROPE BV Avantes Berndorf Band GmbH BIOTECON Diagnostics GmbH Bruker BioSpin Cargo Oil AB DuPont Nutrition & Health Elea GmbH Engilico FUCHS LUBRITECH GmbH GLOBALG.A.P. Foodplus GmbH InS Services (UK) Ltd IONICON Analytik GmbH JAX INC. JBT Corporation LUBRIPLATE Lubricants Company NETZSCH Pumpen & Systeme GmbH NSF International Ocean Optics PCE Instruments UK Ltd R-Biopharm Rhone Ltd Sandvik Process Systems Stancold SteriBeam The Tintometer® Group Thermo Fisher Scientific TOMRA Sorting Food Uhde High Pressure Technologies GmbH Verner Wheelock Vikan UK Ltd Wenger